IO Biotech, Inc. (IOBTQ) Total Non-Current Liabilities (2020 - 2025)

IO Biotech (IOBTQ) has 6 years of Total Non-Current Liabilities data on file, last reported at $20.7 million in Q3 2025.

• Quarterly Total Non-Current Liabilities rose 1464.83% year-over-year to $20.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $20.7 million (up 1464.83% YoY) and the FY2024 annual result came in at $1.2 million, down 34.86% from the prior year.
• Total Non-Current Liabilities was little changed at $20.7 million in Q3 2025, from $20.8 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $20.8 million in Q2 2025 to a low of $59000.0 in Q4 2021.
• A 5-year average of $4.5 million and a median of $1.8 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2021 — Total Non-Current Liabilities plunged 98.07% — and 2022, when it soared 3755.93%.
• Tracing IOBTQ's Total Non-Current Liabilities over 5 years: stood at $59000.0 in 2021, then soared by 3755.93% to $2.3 million in 2022, then declined by 19.16% to $1.8 million in 2023, then tumbled by 34.86% to $1.2 million in 2024, then jumped by 1630.72% to $20.7 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $20.7 million (Q3 2025), $20.8 million (Q2 2025), and $1.0 million (Q1 2025), per Business Quant data.